Publication: Hepatitis E Virus Seroprevalence is Associated with Neurodegenerative Disorders in Older People with Dementia: A Case-Control Study
dc.contributor.author | Perez-Garcia, Felipe | |
dc.contributor.author | Vázquez-Morón, Sonia | |
dc.contributor.author | Burgueño-García, Iván | |
dc.contributor.author | Muñoz-Gómez, María José | |
dc.contributor.author | Zea-Sevilla, María Ascensión | |
dc.contributor.author | Calero, Miguel | |
dc.contributor.author | Martinez, Isidoro | |
dc.contributor.author | Rábano, Alberto | |
dc.contributor.author | Resino, Salvador | |
dc.contributor.funder | Centro de Investigación Biomédica en Red - CIBERINFEC (Enfermedades Infecciosas) | es_ES |
dc.contributor.funder | Agencia Estatal de Investigación (España) | es_ES |
dc.date.accessioned | 2024-01-24T14:10:00Z | |
dc.date.available | 2024-01-24T14:10:00Z | |
dc.date.issued | 2023-04-12 | |
dc.description.abstract | In this case-control study, we evaluated the association between serum antibodies against hepatitis E virus (HEV) and central nervous system (CNS) neurodegenerative disorders (NDs) in older people with dementia. The presence of anti-HEV antibodies was related to a higher adjusted odds ratio (aOR) of having CNS NDs by neuropathological diagnosis (aOR, 2.13; P = .007) and clinical/neuropathological diagnosis (1.84; P = .02). Besides, serum anti-HEV antibodies were directly related to neuropathological injury (higher vascular pathology [aOR, 1.97; P = .006]) and higher probability of Alzheimer-type pathology (1.84; P = .02). In conclusion, the presence of anti-HEV antibodies was related to higher odds of CNS NDs and neuropathological injury in older people. | es_ES |
dc.description.peerreviewed | Sí | es_ES |
dc.description.sponsorship | This work was supported by awards from the Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (grant CB21/13/00044 to S. R.) and Agencia Estatal de Investigación (grant PID2019-110401RB-100 to M. C.). | es_ES |
dc.format.number | 7 | es_ES |
dc.format.page | 873-877 | es_ES |
dc.format.volume | 227 | es_ES |
dc.identifier.citation | J Infect Dis. 2023 Apr 12;227(7):873-877. | es_ES |
dc.identifier.doi | 10.1093/infdis/jiac268 | es_ES |
dc.identifier.e-issn | 1537-6613 | es_ES |
dc.identifier.journal | The Journal of infectious diseases | es_ES |
dc.identifier.pubmedID | 35759220 | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/17363 | |
dc.language.iso | eng | es_ES |
dc.publisher | Oxford University Press | es_ES |
dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/PID2019-110401RB-100 | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/CB21/13/00044 | es_ES |
dc.relation.publisherversion | https://doi.org/10.1093/infdis/jiac268 | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
dc.repisalud.centro | ISCIII::Unidad Funcional de Investigación de Enfermedades Crónicas (UFIEC) | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.rights.accessRights | open access | es_ES |
dc.rights.license | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Alzheimer | es_ES |
dc.subject | Hepatitis E virus | es_ES |
dc.subject | Neurodegenerative disorders | es_ES |
dc.subject | Older people | es_ES |
dc.subject | Seroprevalence | es_ES |
dc.subject | Vascular pathology | es_ES |
dc.subject.mesh | Hepatitis E virus | es_ES |
dc.subject.mesh | Hepatitis E | es_ES |
dc.subject.mesh | Neurodegenerative Diseases | es_ES |
dc.subject.mesh | Dementia | es_ES |
dc.subject.mesh | Humans | es_ES |
dc.subject.mesh | Aged | es_ES |
dc.subject.mesh | Seroepidemiologic Studies | es_ES |
dc.subject.mesh | Case-Control Studies | es_ES |
dc.subject.mesh | Hepatitis Antibodies | es_ES |
dc.subject.mesh | Immunoglobulin M | es_ES |
dc.title | Hepatitis E Virus Seroprevalence is Associated with Neurodegenerative Disorders in Older People with Dementia: A Case-Control Study | es_ES |
dc.type | research article | es_ES |
dc.type.hasVersion | SMUR | es_ES |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 2d150dc2-661b-4d69-897f-6b8a80b31861 | |
relation.isAuthorOfPublication | 67f2bc43-2edd-4446-a434-c8145a43f451 | |
relation.isAuthorOfPublication | 0a5ce675-0dc5-483a-b8be-b573f3757285 | |
relation.isAuthorOfPublication | 7b0177ec-7b89-4d97-813b-14c5ae64fc28 | |
relation.isAuthorOfPublication | 91fafbb0-4d25-4be8-969e-5b9941af71ca | |
relation.isAuthorOfPublication | 89b17350-14e3-4dfd-b797-6ee6ca5363b8 | |
relation.isAuthorOfPublication.latestForDiscovery | 2d150dc2-661b-4d69-897f-6b8a80b31861 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Hepatitis_E_VirusSeroprevalence_2023.pdf
- Size:
- 1.79 MB
- Format:
- Adobe Portable Document Format
- Description: